🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PRO
$PROK
🔒 US EquitiesProKidney Corp
AVG HISTORICAL GAP
+0.59%
MAX GAP RECORD
-4.73%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PROK
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PROK
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE) |
-4.73%
|
| May 15, 2026 Earnings Release 2026-05-15 (BEFORE OPEN) |
+0.58%
|
| Mar 18, 2026 Earnings Release 2026-03-18 (AFTER CLOSE) |
-0.96%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE) |
+2.96%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+0.45%
|
| May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE) |
+1.47%
|
| Mar 17, 2025 Earnings Release 2025-03-17 (BEFORE OPEN) |
-1.42%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN) |
-0.47%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.0%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (4)
📖 Intelligence Summary
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD….
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗